Details
of Capital Employed for the Drug under study
Rs./Kg
| S.NO. | PARTICULAR | -- |
-- |
-- |
-- |
|---|---|---|---|---|---|
| 1. | Net Fixed Assets | -- |
-- |
-- |
-- |
| 2. | Working Capital | -- |
-- |
-- |
-- |
| 3. | Capital Employed | -- |
-- |
-- |
-- |
Note:- Basis of Working may be indicated.
Proforma VIII
Details of Foreign Exchange repatriated during the last two years
Rs. in lakhs
| S.NO. | PARTICULAR | Gross Amount | Net Amount |
|---|---|---|---|
| 1. | Royalty | -- |
-- |
| 2. | Technical Know-how fees |
-- |
-- |
| 3. | Licence fee |
-- |
-- |
| 4. | Dividend | -- |
-- |
| 5. | Salary/Consultancy paid to foreign experts |
-- |
-- |
| 6. | Any other payments |
-- |
-- |
Note:- If any Royalty/Technical know-how fees/Licence fee is paid/payable, a copy of the related agreements may be attached and the rate of payment, its basis and computation may be indicated.
Proforma IX
Details of Import of Bulk Drug during last two years
Note:- The above details may be given consignment wise.
| Name of the drug (Kgs) | Quantity imported | CIF Value In Foreign Currency | Percentage of Customs Duty |
|---|---|---|---|
| 1 | 2 | 3 | 4 |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
Proforma X
Details of import of Raw Material duty free under advance Licence/any other scheme currently in vogue during the last two years.
| Name of the raw material (Kgs.) | Quantity imported | CIF in foreign Currency | Value in Indian Rupees |
|---|---|---|---|
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
Proforma XI
Details of R&D & ETP Expenditure for the drug under study for the last two years.
| S.No. | Particulars | Capital Expenditure | Revenue Expenditure | ||
|---|---|---|---|---|---|
| -- | -- | R&D | ETP | R&D | ETP |
| I | Capital Cost | -- | -- | -- | -- |
| II | Depreciation | -- | -- | -- | -- |
| III | Operating Expenses | -- | -- | -- | -- |
| a | Materials | -- | -- | -- | -- |
| b | Salaries & Wages | -- | -- | -- | -- |
| c | Other Expense | -- | -- | -- | -- |
Figures in Rs./Lakhs
Note :- Amount proposed to be allocated to the product indicating the basis of allocation (along with supporting data) may also be provided.
Last Page Updated: 01-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)